期刊文献+

CA125、CA19-9、YKL-40、AKT、p-AKT联合检测诊断子宫内膜癌的临床价值 被引量:1

Clinical value exploration of CA125,CA19-9,YKL-40,AKT,p-AKT level combined diagnosis for endometrial cancer
原文传递
导出
摘要 目的探讨血清糖链抗原125(CA125)、糖链抗原19-9(CA19-9)、甲壳质酶蛋白40(YKL-40)、蛋白激酶B(AKT)、磷酸化蛋白激酶B(p-AKT)联合检测诊断子宫内膜肿瘤的临床价值。方法选取子宫内膜癌患者100例为观察组;同期收集于我院体检中心体检健康的成年健康女性100例为对照组。检测2组研究对象CA125、CA19-9的阳性表达率,及YKL-40、AKT、p-AKT水平。比较各指标单独检测和联合检测的敏感度、特异度、准确度。结果观察组血清CA125和CA19-9的阳性表达率均高于对照组,差异均有统计学意义(P<0.05);经血清学检测,观察组血清YKL-40、AKT、p-AKT水平均高于对照组,差异均有统计学意义(P<0.05)。各血清指标单项检测的敏感度、特异度及准确度均低于联合检测,差异均有统计学意义(P<0.05)。结论子宫内膜癌患者具有较高的CA125、CA19-9阳性表达率和较高的YKL-40、AKT、p-AKT血清水平;CA125、CA19-9、YKL-40、AKT、p-AKT联合检测对诊断子宫内膜癌具有较高的临床价值,值得临床推广应用。 Objective To explore the clinical value of CA 125,CA19-9,YKL 40,AKT,p-AKT level combined diag-nosis for uterine endometrial cancer .Methods 100 cases diagnosed with endometrial cancer were selected as observation group;100 healthy women were selected as control group .The positive expression rate of CA 125,CA19-9 and the level of YKL-40,AKT,p-AKT were tested,and calculate the sensitivity ,specificity,accuracy of each index separate detection and combined detection.Results The positive expression rate of CA125 and CA19-9 of observation group were higher than those of normal group,the differences were statistically significant (P〈0.05);The level of serum YKL-40,AKT,p-AKT of observation group were higher than those of normal group ,the difference were statistically significant (P〈0.05).The serum indexes separate de-tection sensitivity ,specificity and accuracy were lower than the joint detection ,the differences were statistically significant ( P〈0.05).Conclusion Patients with endometrial cancer are presented with high positive expression rate of CA 125,CA19-9 and high level of serum YKL-40,AKT,p-AKT.Clinical value of CA125,CA19-9,YKL-40,AKT,p-AKT combined detection in the diagnosis of endometrial cancer is higher ,and it is worthy of clinical application .
出处 《临床合理用药杂志》 2015年第7期32-33,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 肿瘤标志物 子宫内膜癌 联合诊断 Tumor marker Endometrial cancer Joint diagnosis
  • 相关文献

参考文献7

二级参考文献83

  • 1Giudice LC,Kao LC.Endometriosis.Lancet,2004,364:1789-1799.
  • 2Moore RG,Brown AK,Miller MC,et al.The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.Cynecol Oncol,2008,108:402-408.
  • 3Havrilesky LJ,Whitehead CM,Rubatt JM,et al.Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.Gynecol Oncol,2008,110:374-382.
  • 4Drapkin R,von Horsten HH,Lin Y,et al.Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.Cancer Res,2005,65:2162-2169.
  • 5Galgano MT,Hampton GM,Frierson HF Jr.Comprehensive analysis of HE4 expression in normal and malignant human tissues.Mod Pathol,2006,19:847-853.
  • 6Moore RG,Brown AK,Miller MC,et al.Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.Gynecol Oncol,2008,110:196-201.
  • 7Cagnon A,Ye B.Discovery and application of protein biomarkers for ovarian cancer.Curr Opin Obstet Gynecol,2008,20:9-13.
  • 8Kirchhoff C, Habben I, Ivell R,et al. A major human epididymis-specific eDNA encodes a protein with sequence homology to extracellular proteinase inhibitors [ J ]. Biol Reprod, 1991,45 (2) : 350-357.
  • 9Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues [ J ]. Mod Pathol,2006,19 ( 6 ) :847-53.
  • 10Huhtinen K, Suvitie P, Hiissa J,et al. Serum HFA concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts [ J ]. Br J Cancer, 2009,100 ( 8 ) : 1315-1319.

共引文献169

同被引文献6

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部